Translocation Renal Cell Carcinoma
Also known as: MiT family translocation renal cell carcinoma (disorder) / MiT family translocation renal cell carcinoma (morphologic abnormality)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB08875 | Cabozantinib | 2 | Recruiting | 1 |
| DB06186 | Ipilimumab | 2 | Recruiting | 1 |
| DB09035 | Nivolumab | 2 | Recruiting | 1 |